Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (51-60 of 272) with videos related to

Pageof 28
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|March 24, 2023
Positron Emission Tomography-Based Immunoimaging for Cancer Patient Stratification: Toward a More Holistic ApproachAntonia Dimitrakopoulou-Strauss, Christos Sachpekidis, Jessica C Hassel, et al.
JAMA Dermatology|November 6, 2024
Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin SyndromeRobin Reschke, Jasmin Richter, Alexander H Enk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 15, 2011
[Multiple, flesh-coloured, firm, grouped papulonoduleson the right forehead]Barbara M Gaus, Ferdinand Toberer, Alexander Enk, et al.
Journal of Cutaneous Pathology|January 15, 2016
Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinomaMarta Kogut, Ferdinand Toberer, Alexander H Enk, et al.
Frontiers in Immunology|April 2, 2024
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?Robin Reschke, Benjamin Deitert, Alex H Enk, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2021
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatmentSophia B Strobel, Devayani Machiraju, Katharina A Kälber, et al.
EJNMMI Research|September 8, 2021
Assessment of early metabolic progression in melanoma patients under immunotherapy: an <sup>18</sup>F-FDG PET/CT studyChristos Sachpekidis, Annette Kopp-Schneider, Jessica C Hassel, et al.
Immunotherapy|July 14, 2021
Durable complete remission of leptomeningeal melanoma by intrathecal methotrexate maintained with systemic ipilimumabCarmen Dietrich, Martin Salzmann, Andreas Steinbrecher, et al.
Onkologie|March 11, 2010
Treatment of epidermal growth factor receptor antagonist-induced skin rash: results of a survey among German oncologistsJessica C Hassel, Melanie Kripp, Salah Al-Batran, et al.
Academic Radiology|March 19, 2013
Therapy response assessment in metastatic melanoma patients treated with a BRAF inhibitor: adapted Choi criteria can reflect early therapy response better than does RECISTMonika Uhrig, Jessica C Hassel, Heinz-Peter Schlemmer, et al.
Pageof 28

Showing results (51-60 of 272) with videos related to

Sort By:
Pageof 28
Cancer Biotherapy & Radiopharmaceuticals|March 24, 2023
Positron Emission Tomography-Based Immunoimaging for Cancer Patient Stratification: Toward a More Holistic ApproachAntonia Dimitrakopoulou-Strauss, Christos Sachpekidis, Jessica C Hassel, et al.
JAMA Dermatology|November 6, 2024
Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin SyndromeRobin Reschke, Jasmin Richter, Alexander H Enk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 15, 2011
[Multiple, flesh-coloured, firm, grouped papulonoduleson the right forehead]Barbara M Gaus, Ferdinand Toberer, Alexander Enk, et al.
Journal of Cutaneous Pathology|January 15, 2016
Limitations of Ber-EP4 for distinction of Bowen disease from basal cell carcinomaMarta Kogut, Ferdinand Toberer, Alexander H Enk, et al.
Frontiers in Immunology|April 2, 2024
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?Robin Reschke, Benjamin Deitert, Alex H Enk, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2021
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatmentSophia B Strobel, Devayani Machiraju, Katharina A Kälber, et al.
EJNMMI Research|September 8, 2021
Assessment of early metabolic progression in melanoma patients under immunotherapy: an <sup>18</sup>F-FDG PET/CT studyChristos Sachpekidis, Annette Kopp-Schneider, Jessica C Hassel, et al.
Immunotherapy|July 14, 2021
Durable complete remission of leptomeningeal melanoma by intrathecal methotrexate maintained with systemic ipilimumabCarmen Dietrich, Martin Salzmann, Andreas Steinbrecher, et al.
Onkologie|March 11, 2010
Treatment of epidermal growth factor receptor antagonist-induced skin rash: results of a survey among German oncologistsJessica C Hassel, Melanie Kripp, Salah Al-Batran, et al.
Academic Radiology|March 19, 2013
Therapy response assessment in metastatic melanoma patients treated with a BRAF inhibitor: adapted Choi criteria can reflect early therapy response better than does RECISTMonika Uhrig, Jessica C Hassel, Heinz-Peter Schlemmer, et al.
Pageof 28